$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Prolonged release microcapsule and its production 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/52
  • B01J-013/02
출원번호 US-0667096 (1984-11-01)
우선권정보 JP-0207760 (1983-11-04)
발명자 / 주소
  • Okada Hiroaki (Suita JPX) Ogawa Yasuaki (Ibaraki JPX) Yashiki Takatsuka (Takarazuka JPX)
출원인 / 주소
  • Takeda Chemical Industries, Ltd. (Osaka JPX 03)
인용정보 피인용 횟수 : 253  인용 특허 : 3

초록

A microcapsule produced by preparing a water-in-oil emulsion comprising an inner aqueous layer containing said water-soluble drug and a drug retaining substance therefor and an oil layer containing a polymer substance, then thickening or solidifying said inner aqueous layer to a viscosity of not low

대표청구항

A prolonged release microcapsule having an average diameter of about 2 to 200m5000 centipoises and finally admixing the resulting emulsion with a third aqueous layer to give a water/oil/water ternary layer emulsion and then desorbing the solvent in the oil layer.

이 특허에 인용된 특허 (3)

  1. Jaffe Howard (Gaithersburg MD), Microencapsulation process.
  2. Nestor John J. (San Jose CA) Jones Gordon H. (Cupertino CA) Vickery Brian H. (Cupertino CA), Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone.
  3. Nevin Robert S. (Indianapolis IN), Polymerization process and product.

이 특허를 인용한 특허 (253)

  1. Shih Chung ; Zentner Gaylen M., Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof.
  2. Shih, Chung; Zentner, Gaylen, Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles.
  3. Shih, Chung; Zentner, Gaylen M., Biodegradable block copolymeric compositions for drug delivery.
  4. Shih, Chung; Zentner, Gaylen M., Biodegradable block copolymeric compositions for drug delivery.
  5. Shih, Chung; Zentner, Gaylen M., Biodegradable block copolymeric compositions for drug delivery.
  6. Rathi Ramesh C. ; Zentner Gaylen M. ; Jeong Byeongmoon, Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties.
  7. Rathi Ramesh C. ; Zentner Gaylen M. ; Jeong Byeongmoon, Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties.
  8. Rathi Ramesh C. ; Zentner Gaylen M., Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties.
  9. Dunn, Richard L; English, James P., Biodegradable polymer composition.
  10. Richard L Dunn ; James P. English, Biodegradable polymer composition.
  11. Berde Charles B. (Brookline MA) Langer Robert S. (Newton MA), Biodegradable polymer matrices for sustained delivery of local anesthetic agents.
  12. Berde Charles B. ; Langer Robert S., Biodegradable polymer matrices for sustained delivery of local anesthetic agents.
  13. Zhang, Junshou, Biologically active oral preparation that can be site-specific released in colon.
  14. Masters, David B.; Berg, Eric Peter, Biomatrix structural containment and fixation systems and methods of use thereof.
  15. Soula, Rémi; Pouliquen, Gauthier; Chan, You-Ping, Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications.
  16. Latta, Mark A.; Gross, Stephen M.; McHale, William A., Buffered microencapsulated compositions and methods.
  17. Smith, Thomas J., Coated particles for sustained-release pharmaceutical administration.
  18. Soula, Gérard; Bryson, Nathan, Colloidal suspension of nanoparticles based on an amphiphilic copolymer.
  19. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo, Composition comprising oil drops.
  20. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo, Composition comprising oil drops.
  21. Orsolini Piero (Martigny CHX) Heimgartner Frederic (Martigny CHX), Composition for the sustained and controlled release of medicamentous substances and a process for preparing the same.
  22. Sanders, Steven W.; Ebert, Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  23. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  24. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  25. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  26. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  27. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  28. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
  29. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
  30. Hustvedt, Svein Olaf; Olesen, Preben Houlberg; Berge, Gunnar; Mullertz, Anette, Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof.
  31. Hustvedt, Svein Olaf; Olesen, Preben Houlberg; Berge, Gunnar; Müllertz, Anette, Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof.
  32. Fraser, David A; Garras, Alexis, Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof.
  33. Cleland, Jeffrey L.; Lim, Amy; Powell, Michael Frank, Compositions for microencapsulation of antigens for use as vaccines.
  34. Riscoe, Michael K.; Winter, Rolf W.; Pou, Sovitj; Hinrichs, David J.; Kelly, Jane Xu; Li, Yuexin; Nilsen, Aaron, Compounds, compositions and associated methods comprising 3-aryl quinolines.
  35. Riscoe, Michael K.; Winter, Rolf W.; Pou, Sovitj; Hinrichs, David J.; Kelly, Jane Xu; Li, Yuexin; Nilsen, Aaron, Compounds, compositions and associated methods comprising 3-aryl quinolines.
  36. Boutignon, Francois, Compressed microparticles for dry injection.
  37. Kim, Yi Mi; Lim, Sun Kyung; Park, Mi Ran; Park, Young Joon; Baek, Seung Hee; Shin, Hyun Woo, Continuous process for preparing microspheres and microspheres prepared thereby.
  38. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
  39. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
  40. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
  41. Yamamoto,Kazumichi; Yamada,Akiko; Hata,Yoshio, Controlled release composition and method of producing the same.
  42. Baker Richard W. (Menlo Park CA), Controlled release drug delivery system for the periodontal pocket.
  43. Cheng, Xiu Xiu; Jan, Steve; Chou, Joseph; Chen, Chih-Ming, Controlled release metformin formulations.
  44. Xiu Xiu Cheng ; Chih-Ming Chen ; Steve Jan ; Joseph Chou, Controlled release oral tablet having a unitary core.
  45. Eley John Graham, Controlled, phased-release suppository and its method of production.
  46. Cheng, Jianjun; Davis, Mark E.; Khin, Kat T., Cyclodextrin-based polymers for therapeutics delivery.
  47. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  48. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  49. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  50. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  51. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  52. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  53. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  54. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  55. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  56. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  57. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  58. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  59. Cheng, Jianjun; Davis, Mark; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  60. Cheng, Jianjun; Davis, Mark; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  61. Cheng,Jianjun; Davis,Mark E.; Khin,Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  62. Davis, Mark E.; Hwang, Jungyeon; Ke, Tianyi; Lim, Ching-Jou; Schluep, Thomas, Cyclodextrin-based polymers for therapeutics delivery.
  63. Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakis, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
  64. Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakls, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
  65. Ni,Yawei; Yates,Kenneth M., Delivery of physiological agents with in-situ gels comprising anionic polysaccharides.
  66. Evans, Douglas G.; Goldman, Scott M.; Kronengold, Russell T., Devices and methods for treating defects in the tissue of a living being.
  67. Evans, Douglas G; Goldman, Scott M.; Kronengold, Russell T., Devices and methods for treating defects in the tissue of a living being.
  68. Evans, Douglas G; Goldman, Scott M.; Kronengold, Russell T., Devices and methods for treating defects in the tissue of a living being.
  69. Evans, Douglas G; Goldman, Scott M.; Kronengold, Russell T., Devices and methods for treating defects in the tissue of a living being.
  70. Evans, Douglas G; Goldman, Scott M.; Kronengold, Russell T., Devices and methods for treating defects in the tissue of a living being.
  71. Evans, Douglas G; Goldman, Scott M.; Kronengold, Russell T., Devices and methods for treating defects in the tissue of a living being.
  72. Evans, Douglas G; Goldman, Scott M.; Kronengold, Russell T., Devices and methods for treating defects in the tissue of a living being.
  73. Evans, Douglas G; Goldman, Scott M.; Kronengold, Russell T., Devices and methods for treating defects in the tissue of a living being.
  74. Evans,Douglas G.; Goldman,Scott M.; Kronengold,Russell T., Devices and methods for treating defects in the tissue of a living being.
  75. Evans,Douglas G.; Goldman,Scott M.; Kronengold,Russell T., Devices and methods for treating defects in the tissue of a living being.
  76. Evans,Douglas G.; Goldman,Scott M.; Kronengold,Russell T., Devices and methods for treating defects in the tissue of a living being.
  77. Evans,Douglas G; Goldman,Scott M.; Kronengold,Russell T., Devices and methods for treating defects in the tissue of a living being.
  78. Ostroff, Gary R., Drug delivery product and methods.
  79. Ostroff, Gary R., Drug delivery product and methods.
  80. Ostroff, Gary R., Drug delivery product and methods.
  81. Dunn,Richard L., Emulsions for in-situ delivery systems.
  82. McHale, William A.; Brown, Dale G., Enamel protectant and repair brushing gels.
  83. Mchale, William A.; Brown, Dale G., Enamel protectant and repair toothpaste.
  84. Mchale, William A.; Brown, Dale G., Enamel protectant and repair toothpaste treatments.
  85. Czech, Michael P.; Ostroff, Gary R.; Aouadi, Myriam, Encapsulated nanoparticles for nucleic acid delivery.
  86. Masters, David B.; Berg, Eric P., Encapsulated or coated stent systems.
  87. Laakso, Timo; Reslow, Mats, Encapsulation method.
  88. Heya Toshiro (Hyogo JPX) Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Kyoto JPX), Encapsulation of TRH or its analog.
  89. Farrar Graham Henry,GBX ; Tinsley-Bown Anne Margaret,GBX ; Jones David Hugh,CAX, Encapsulation of bioactive agents.
  90. Cleland Jeffrey L. ; Jones Andrew J. S., Excipient stabilization of polypeptides treated with organic solvents.
  91. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Monica Torres, Formulations.
  92. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Mónica, Formulations.
  93. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, Formulations and methods for providing prolonged local anesthesia.
  94. Charles B. Berde ; Robert S. Langer ; Joanne Curley ; Jenny Castillo, Formulations and methods for providing prolonged local anesthesia.
  95. Chasin Mark ; Sackler Richard ; Burch Ronald M. ; Goldenheim Paul ; Tigner Joseph, Formulations and methods for providing prolonged local anesthesia.
  96. Chasin, Mark; Goldenheim, Paul; Sackler, Richard; Tigner, Joseph; Burch, Ronald M, Formulations and methods for providing prolonged local anesthesia.
  97. Chasin, Mark; Sackler, Richard; Burch, Ronald M.; Goldenheim, Paul; Tigner, Joseph, Formulations and methods for providing prolonged local anesthesia.
  98. Chasin, Mark; Sackler, Richard; Burch, Ronald M.; Goldenheim, Paul; Tigner, Joseph, Formulations and methods for providing prolonged local anesthesia.
  99. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, High load formulations and methods for providing prolonged local anesthesia.
  100. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, High load formulations and methods for providing prolonged local anesthesia.
  101. Ni, Yawei; Yates, Kenneth M.; Zarzycki, Ryszard, High molecular weight, low methoxyl pectins, and their production and uses.
  102. Loiseau, Anthony; Chen, Yiyan; Panga, Mohan K. R., Hydrolyzable particle compositions, treatment fluids and methods.
  103. Aversa, Vincenzo; Coulter, Ivan; Rosa, Mónica Torres; McDonald, Bernard Francis, Immunomodulatory compositions.
  104. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Monica Torres; Lavelle, Edward Charles, Immunomodulatory compositions comprising a polymer matrix and an oil phase.
  105. Ni, Yawei; Yates, Kenneth M., In-situ gel formation of pectin.
  106. Albayrak,Celal, Induced phase transition method for the production of microparticles containing hydrophilic active agents.
  107. Albayrak, Celal, Induced phase transition method for the production of microparticles containing hydrophobic active agents.
  108. Kamens, Joanne; Khvorova, Anastasia, Inhibition of PCSK9 through RNAI.
  109. Tice,Thomas R.; Staas,Jay K.; Ferrell,Teresa M.; Markland,Peter, Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances.
  110. Helliwell, James A.; Malone, Amanda M.; Smith, Thomas J.; Baum, Marc M., Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith.
  111. Chou, Kang-Jye; Guo, Hong; Ashton, Paul; Shimizu, Robert W.; Watson, David A., Injectable sustained release delivery devices.
  112. Cleland, Jeffrey L.; Lam, Xanthe M.; Okumu, Franklin, Injection vehicle for polymer-based formulations.
  113. Cleland, Jeffrey L.; Lam, Xanthe M.; Okumu, Franklin, Injection vehicle for polymer-based formulations.
  114. Prestrelski, Steven; Brodbeck, Kevin, Intracutaneous paste composition.
  115. Yamamoto, Kohei; Tani, Tsutomu; Aoki, Takashi; Hata, Yoshio, Lactic acid polymer and process for producing the same.
  116. Hamaguchi Naoru (Ibaraki JPX) Iga Katsumi (Suita JPX) Ogawa Yasuaki (Ibaraki JPX), Liposome composition.
  117. Bohm Howard A. (Richmond VA), Liquid controlled release formulations and method of producing same via multiple emulsion process.
  118. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D., Macromolecular microparticles and methods of production and use.
  119. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D., Macromolecular microparticles and methods of production and use.
  120. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D. ; Riske Frank J., Macromolecular microparticles and methods of production and use.
  121. Coulter, Ivan, Manufacture of multiple minicapsules.
  122. Coulter, Ivan, Manufacture of multiple minicapsules.
  123. Moyano, Nora; Iturraspe, Jose; Nunez, Jose Lucio, Manufacturing process of microcapsules for sustained release of water soluble peptides.
  124. Dittgen Michael,DEX ; Fricke Sabine,DEX ; Graser Thomas,DEX ; Osterwald Hermann,DEX ; Oettel Michael,DEX ; Lippert Theodor Hermann,DEX, Melatonin for the production of a peroral pulsatile form of medication.
  125. Wang, James H.; Shi, Bo; Lee, JaeHong; Topolkaraev, Vasily A.; Scholl, Neil T.; Kim, YoungSook, Melt processed antimicrobial composition.
  126. Topolkaraev, Vasily A.; Scholl, Neil T., Melt-blended protein composition.
  127. Topolkaraev, Vasily A.; Scholl, Neil T., Melt-blended protein composition.
  128. Parente Dueña, Antonio; Garcés Garcés, Josep; Bonilla Muñoz, Angel; Cunillera Colomé, David, Method for delivering a peptide to a subject at a modulated rate via microcapsules of lactic-co-glycolic copolymer containing said peptide.
  129. Cleland Jeffrey L. ; Jones Andrew J. S. ; Powell Michael Frank, Method for drying microspheres.
  130. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Method for producing microcapsule.
  131. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Method for producing microcapsule.
  132. Yamamoto Masaki (Osaka JPX) Takada Shigeyuki (Suita JPX) Ogawa Yasuaki (Ibaraki ; all JPX), Method for producing microcapsule.
  133. van Buitenen,Adrianus Franciscus G.; Verrijk,Rudolf, Method for the preparation of purified microparticles.
  134. Ashton, Paul, Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
  135. Soper Jon C. ; Kim Young D. ; Thomas Margaret T., Method of encapsulating flavors and fragrances by controlled water transport into microcapsules.
  136. Soper Jon C. ; Yang Xiaogen ; Josephson David B., Method of encapsulating flavors and fragrances by controlled water transport into microcapsules.
  137. Jones David Hugh,GBX ; Farrar Graham Henry,GBX ; Clegg James Christopher Stephen,GBX, Method of making microencapsulated DNA for vaccination and gene therapy.
  138. Jones, David Hugh; Farrar, Graham Henry; Clegg, James Christopher Stephen, Method of making microencapsulated DNA for vaccination and gene therapy.
  139. Han, Dong Keun; Park, Kwideok; Kim, Jae-Jin; Son, Jun Sik; Bae, Soon Eon, Method of preparing covered porous biodegradable polymer microspheres for sustained-release drug delivery and tissue regeneration.
  140. Kim, Yi Mi; Park, Young Joon; Baek, Seung Hee; Lim, Sun Kyung, Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby.
  141. Kelleher-Andersson, Judith, Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration.
  142. Kelleher-Andersson, Judith, Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration.
  143. Kelleher-Andersson, Judith, Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones.
  144. Kelleher-Andersson, Judith, Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones.
  145. Kelleher-Andersson, Judith, Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones.
  146. Kelleher-Anderson, Judith, Methods and compositons for stimulating neurogenesis and inhibiting neuronal degeneration.
  147. Garnick Marc B., Methods for detecting lesions in dense breast tissue using LHRH antagonists.
  148. Garnick, Marc B., Methods for detecting lesions in dense breast tissue using LHRH antagonists.
  149. Garnick, Marc B., Methods for detecting lesions in dense breast tissue using LHRH antagonists.
  150. Brown, Larry; McGeehan, John K.; Rashba-Step, Julia; Scott, Terrence L., Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation.
  151. McHale, William A.; Brown, Dale G., Methods for protecting and reparing enamel.
  152. Sackler, Richard S.; Goldenheim, Paul D.; Chasin, Mark; Burch, Ronald M.; Reder, Robert F.; Tigner, Joseph, Methods for providing safe local anesthesia.
  153. Darvari, Ramin; Lambert, Adam; Rashba-Step, Julia E.; Yang, Mark X.; Zhang, Junhong; O'Connell, Ed, Methods of processing compositions containing microparticles.
  154. Piran, Uri; Mehr, Eugene; Brown, Larry R.; McGeehan, John K.; O'Connell, Ed, Methods of processing compositions containing microparticles.
  155. Piran, Uri, Methods of processing multi-phasic dispersions.
  156. Hartman, Ryan; Panga, Mohan K. R.; Drochon, Bruno; Still, John W.; Abad, Carlos; Garcia-Lopez De Victoria, Marieliz; England, Kevin W.; Aviles, Isaac, Methods to deliver fluids on a well site with variable solids concentration from solid slurries.
  157. Grisoni,Philippe, Microcapsule powder.
  158. Mumper,Russell John; Jay,Michael, Microemulsions as precursors to solid nanoparticles.
  159. Jones, David Hugh; Farrar, Graham Henry; Clegg, James Christopher Stephen, Microencapsulated DNA for vaccination and gene therapy.
  160. Latta, Mark A.; Gross, Stephen M.; Mchale, William A., Microencapsulated compositions and methods for tissue mineralization.
  161. Brown, Larry R.; Giannoukakis, Nick; Gillis, Kimberly A.; Trucco, Massimo, Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes.
  162. Piao,Ai Zhi; Shih,Chung, Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties.
  163. Piao,Ai Zhi; Shih,Chung, Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties.
  164. Masters, David B.; Berg, Eric P., Mucoadhesive drug delivery devices and methods of making and using thereof.
  165. Kalombo, Lonji, Nanoparticle carriers for drug administration and process for producing same.
  166. Ishihara, Tsutomu; Mizushima, Yutaka, Nanoparticles containing water-soluble non-peptide low-molecular weight drug.
  167. Azria Moise (Basel CHX), Nasal pharmaceutical compositions.
  168. Scholl, Neil T.; Topolkaraev, Vasily A., Natural, multiple release and re-use compositions.
  169. Topolkaraev, Vasily A.; Scholl, Neil T.; Kim, YoungSook; Koenig, David W.; Lee, JaeHong, Natural, multiple use and re-use, user saturated wipes.
  170. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Miller, Michelle; Bulock, Karen G., Neutral nanotransporters.
  171. Brown, Larry R.; Scott, Terrence L.; Lafreniere, Debra; Bisker-Leib, Vered, Nucleic acid microspheres, production and delivery thereof.
  172. Scott, Terrence; Lafreniere, Debra; Bisker-Leib, Vered; Brown, Larry, Nucleic acid microspheres, production and delivery thereof.
  173. Coulter, Ivan, Oral pharmaceutical composition.
  174. Coulter, Ivan, Oral pharmaceutical composition.
  175. Coulter, Ivan, Oral pharmaceutical composition.
  176. Castan, Catherine; Guimberteau, Florence; Meyrueix, Rémi, Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s).
  177. Botts,M. Francis; Kohn,Frank C.; Miller,Maria L., Particles containing agricultural active ingredients.
  178. Botts,M. Francis; Kohn,Frank C.; Miller,Maria L., Particles containing agricultural active ingredients.
  179. Prestrelski, Steven; Brodbeck, Kevin, Pastes for injection of a therapeutic agent.
  180. Samarsky, Dmitry; Woolf, Tod M., Phagocytic cell delivery of RNAI.
  181. Coulter, Ivan, Pharmaceutical composition of tacrolimus.
  182. Ni, Yawei; Yates, Kenneth M.; Zarzycki, Ryszard, Pharmaceutical compositions comprising aloe pectins, and methods for their production and use.
  183. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  184. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  185. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  186. Angot, Stéphanie; Breyne, Olivier; Chan, You-Ping; Soula, Gérard, Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof.
  187. Chan, You-Ping; Angot, Stéphanie; Breyne, Olivier, Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications.
  188. Soula, Olivier; Soula, Rémi; Breyne, Olivier, Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes.
  189. Chan, You-Ping; Bonnet-Gonnet, Cecile; Breyne, Olivier, Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof.
  190. Yano, Tetsuya; Nomoto, Tsuyoshi; Kozaki, Shinya; Imamura, Takeshi; Honma, Tsutomu, Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof.
  191. Davis, Mark E.; Hwang, Jungyeon; Ke, Tianyi; Lim, Ching-jou; Schluep, Thomas, Polymer drug conjugates with tether groups for controlled drug delivery.
  192. Yamamoto Masaki (Osaka JPX) Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Miyagawa Tsutomu (Saitama JPX), Polymer, production and use thereof.
  193. Dunn, Richard L.; Garrett, John Steven; Ravivarapu, Harish; Chandrashekar, Bhagya L., Polymeric delivery formulations of leuprolide with improved efficacy.
  194. Rossling, Georg; Albayrak, Celal; Tack, Johannes; Schmitz, Reinhard, Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process.
  195. Lee, Hee-Yong; Kim, Jung-Soo; Shin, Eun-Ho; Kim, Seong-Kyu; Seol, Eun-Young; Baek, Mi-Jin; Baek, Mi-Young; Chae, Yeon-Jin; Choi, Ho-Il; Lee, Juhan, Process of preparing microspheres for sustained release having improved dispersibility and syringeability.
  196. Brown,Larry R., Production of microspheres.
  197. Takechi Nobuyuki,JPX ; Ohtani Seiji,JPX ; Nagai Akihiro,JPX, Production of microspheres.
  198. Hartounian, Hartoun; Meissner, Dagmar; Pepper, Clint B., Production of multivesicular liposomes.
  199. Goldenheim Paul ; Lacouture Peter ; Donigi-Gale Donna ; Chasin Mark ; Sackler Richard, Prolonged anesthesia in joints and body spaces.
  200. Goldenheim, Paul; Donigi-Gale, Donna; Sackler, Richard; Lacouture, Peter; Chasin, Mark, Prolonged anesthesia in joints and body spaces.
  201. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Prolonged release microcapsules.
  202. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Prolonged release microcapsules and their production.
  203. Takada Shigeyuki (Salt Lake City UT) Uda Yoshiaki (Takarazuka JPX) Ogawa Yasuaki (Kyoto JPX), Prolonged release microparticle preparation and production of the same.
  204. Masters, David B., Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof.
  205. Masters, David B.; Berg, Eric P., Protein biomaterials and biocoacervates and methods of making and using thereof.
  206. Masters, David B.; Berg, Eric P., Protein biomaterials and biocoacervates and methods of making and using thereof.
  207. Masters, David B., Protein matrix materials, devices and methods of making and using thereof.
  208. Masters, David B., Protein matrix materials, devices and methods of making and using thereof.
  209. Brown, Larry; Bisker-Leib, Vered; LaFreniere, Debra; McGeehan, John; Rashba-Step, Julia; Scott, Terrence, Protein microspheres having injectable properties at high concentrations.
  210. Brown, Larry R.; Yang, Mark X.; O'Connell, Ed, Protein microspheres retaining pharmacokinetic and pharmacodynamic properties.
  211. Topolkaraev, Vasily A.; Scholl, Neil T.; Lee, JaeHong; Ambrose, Dianna L.; Kim, YoungSook, Protein stabilized antimicrobial composition formed by melt processing.
  212. Topolkaraev, Vasily A.; Scholl, Neil T.; Lee, Jaehong; Ambrose, Dianna L.; Kim, YoungSook, Protein stabilized antimicrobial composition formed by melt processing.
  213. Woolf, Tod M.; Kamens, Joanne; Salomon, William; Khvorova, Anastasia, RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality.
  214. McHale, William A.; Brown, Dale G., Remineralizing and desensitizing compositions, treatments and methods of manufacture.
  215. Dadey, Eric; Zhou, Mingxing, Stabilized polymeric delivery system comprising a water-insoluble polymer and an organic liquid.
  216. Torabinejad, Mahmoud; Moaddel, Homayoun, Substances and method for replacing natural tooth material.
  217. Torabinejad, Mahmoud; Moaddel, Homayoun, Substances and methods for replacing natural tooth material.
  218. Margaron, Philippe Maria Clotaire; Dadey, Eric; Lindemann, Christopher M.; Li, Ruihong, Sustained delivery formulations of rapamycin compounds.
  219. Chen Jianbing ; Ashton Paul, Sustained release drug delivery devices.
  220. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  221. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  222. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  223. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  224. Hong Guo ; Paul Ashton, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  225. Bodmer David,CHX ; Fong Jones W. ; Kissel Thomas,DEX ; Maulding Hawkins V. ; Nagele Oskar,CHX ; Pearson Jane E., Sustained release formulations of water soluble peptides.
  226. Takechi Nobuyuki,JPX ; Ohtani Seiji,JPX ; Nagai Akihiro,JPX, Sustained release microspheres and preparation thereof.
  227. Dunn, Richard L., Sustained release polymer.
  228. Dunn, Richard L., Sustained release polymer.
  229. Dunn, Richard L., Sustained release polymer.
  230. Dunn, Richard L., Sustained release polymer.
  231. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
  232. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
  233. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
  234. Kamei, Shigeru; Igari, Yasutaka; Ogawa, Yasuaki, Sustained-release preparation.
  235. Kamei,Shigeru; Igari,Yasutaka; Ogawa,Yasuaki, Sustained-release preparation.
  236. Saito, Kazuhiro; Futo, Tomomichi; Hoshino, Tetsuo, Sustained-release preparations.
  237. Nash, John E.; Evans, Douglas G.; Hoganson, David M., Systems and methods for delivering agents into targeted tissue of a living being.
  238. Nash, John E.; Evans, Douglas G.; Hoganson, David M., Systems and methods for delivering agents into targeted tissue of a living being.
  239. Nash,John E.; Evans,Douglas G.; Hoganson,David M., Systems and methods for delivering agents into targeted tissue of a living being.
  240. Soula, Rémi; Chan, You-Ping; Soula, Gérard; Breyne, Olivier, Telechelic homopolyamino acids functionalized with hydrophobic groups, and their applications, especially therapeutic applications.
  241. Ginns, Edward I.; Ostroff, Gary R., Therapy for lysosomal enzyme deficiencies.
  242. Ginns, Edward I.; Ostroff, Gary R., Therapy for lysosomal enzyme deficiencies.
  243. Cha Younsik (Salt Lake City UT) Choi Young Kweon (Salt Lake City UT) Bae You Han (Kwangju KRX), Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers.
  244. McHale, William A.; Brown, Dale G., Topical ubiquinol oral supplement compositions with amorphous calcium phosphate.
  245. McHale, William A.; Brown, Dale G., Topical vitamin D and ubiquinol oral supplement compositions.
  246. McHale, William A.; Brown, Dale G., Topical vitamin D oral supplement compositions.
  247. Amagase Harunobu (Hiroshima JPX) Arakawa Masato (Hiroshima JPX) Hashimoto Ken (Hiroshima JPX), Treatment of cancer.
  248. Ebert, Charles D.; Sanders, Steven W., Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy.
  249. Aust, Duncan T.; Jones, David P.; Jovanovic, Aleksa V.; Kulkarni, Vitthal; Kumar, Promod; Shi, Lei, Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa.
  250. Lee, JaeHong; Topolkaraev, Vasily A.; Koenig, David W.; Scholl, Neil T.; Kim, YoungSook; Wang, James H., Wipe coated with a botanical emulsion having antimicrobial properties.
  251. Masters, David B.; Berg, Eric P., Wound treatments with crosslinked protein amorphous biomaterials.
  252. Gibson, John W.; Tipton, Arthur J.; Holl, Richard J.; Meador, Stacey, Zero-order prolonged release coaxial implants.
  253. Gibson, John W.; Tipton, Arthur J.; Holl, Richard; Meador, Stacey, Zero-order prolonged release coaxial implants.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로